Tricida provides update on FDA interactions regarding an appeal denied letter relating to veverimer and metabolic acidosis
Tricida, Inc. provided an update on its FDA interactions. Tricida has received an Appeal Denied Letter (ADL), from the Office of New Drugs (OND) of the FDA in… read more.
